Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Breast Cancer Research and Treatment
Published in: Breast Cancer Research and Treatment 1/2004

01-01-2004

Monitoring Response to Primary Chemotherapy in Breast Cancer using Dynamic Contrast-enhanced Magnetic Resonance Imaging

Authors: Laura Martincich, Filippo Montemurro, Giovanni De Rosa, Vincenzo Marra, Riccardo Ponzone, Stefano Cirillo, Marco Gatti, Nicoletta Biglia, Ivana Sarotto, Piero Sismondi, Daniele Regge, Massimo Aglietta

Published in: Breast Cancer Research and Treatment | Issue 1/2004

Login to get access
Metadata
Title
Monitoring Response to Primary Chemotherapy in Breast Cancer using Dynamic Contrast-enhanced Magnetic Resonance Imaging
Authors
Laura Martincich
Filippo Montemurro
Giovanni De Rosa
Vincenzo Marra
Riccardo Ponzone
Stefano Cirillo
Marco Gatti
Nicoletta Biglia
Ivana Sarotto
Piero Sismondi
Daniele Regge
Massimo Aglietta
Publication date
01-01-2004
Publisher
Kluwer Academic Publishers
Published in
Breast Cancer Research and Treatment / Issue 1/2004
Print ISSN: 0167-6806
Electronic ISSN: 1573-7217
DOI
https://doi.org/10.1023/B:BREA.0000010700.11092.f4

Other articles of this Issue 1/2004

Breast Cancer Research and Treatment 1/2004 Go to the issue

BriefCommunication

Pilot Study using Gabapentin for Tamoxifen-induced Hot Flashes in Women with Breast Cancer

OriginalPaper

Terminal Endbuds and Acini as the Respective Major Targets for Chemical and Sporadic Carcinogenesis in the Mammary Glands of Human c-Ha-ras Protooncogene Transgenic Rats

OriginalPaper

Spectrum of p53 Tumor Suppressor Gene Mutations and Breast Cancer Survival

OriginalPaper

Cost of Illness Associated with Metastatic Breast Cancer

OriginalPaper

Excess Risk for Contralateral Breast Cancer in CHEK2*1100delC Germline Mutation Carriers

OriginalPaper

c-kit and SCF Expression in Normal and Tumor Breast Tissue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits